In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates
Joseph Meletiadis, Paschalis Paranos, Panagiota‐Christina Georgiou, S. Vourli, Stavroula Antonopoulou, Aikaterini Michelaki, Eleni Vagiakou, Spyros Pournaras
Topics & Concepts
CefepimeMeropenemAztreonamMicrobiologyKlebsiella pneumoniaeTigecyclineTazobactamCeftazidimeImipenemMedicineBiologyPseudomonas aeruginosaAntimicrobialAntibioticsAntibiotic resistanceBacteriaEscherichia coliBiochemistryGeneGeneticsAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyAntibiotic Use and Resistance